Martin P Sutter insider trades: Abiomed (NASD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Martin reports to the SEC
and 1 more company
Open-market buys and sales
31 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 16, 2022 | NASD | ↓ Sell | 4,000 | $374.61 | $1.5M | Direct | Nov 17, 2022 (1d) |
| Aug 17, 2022 | NASD | ↓ Sell | 4,000 | $286.39 | $1.1M | Direct | Aug 17, 2022 (0d) |
| May 18, 2022 | NASD | ↓ Sell | 4,000 | $251.20 | $1.0M | Direct | May 19, 2022 (1d) |
| Feb 17, 2022 | ABMD | ↓ Sell | 4,000 | $314.71 | $1.3M | Direct | Feb 17, 2022 (0d) |
| Feb 16, 2022 | ABMD | ↓ Sell10b5-1 | 2,000 | $308.66 | $617K | Direct | Feb 17, 2022 (1d) |
| Feb 15, 2022 | ABMD | ↓ Sell10b5-1 | 2,000 | $303.65 | $607K | Direct | Feb 17, 2022 (2d) |
| Nov 18, 2021 | ABMD | ↓ Sell10b5-1 | 22,500 | $341.86 | $7.7M | Direct | Nov 18, 2021 (0d) |
| Aug 18, 2021 | ABMD | ↓ Sell10b5-1 | 7,500 | $329.82 | $2.5M | Direct | Aug 19, 2021 (1d) |
| May 19, 2021 | ABMD | ↓ Sell10b5-1 | 7,500 | $267.08 | $2.0M | Direct | May 20, 2021 (1d) |
| Feb 17, 2021 | ABMD | ↓ Sell10b5-1 | 7,500 | $322.34 | $2.4M | Direct | Feb 18, 2021 (1d) |
| Nov 18, 2020 | ABMD | ↓ Sell10b5-1 | 1,500 | $268.93 | $403K | Direct | Nov 19, 2020 (1d) |
| Aug 19, 2020 | ABMD | ↓ Sell10b5-1 | 1,500 | $312.19 | $468K | Direct | Aug 20, 2020 (1d) |
| May 4, 2020 | ABMD | ↓ Sell | 12,000 | $180.58 | $2.2M | Direct | May 6, 2020 (2d) |
| May 8, 2019 | ABMD | ↓ Sell | 4,664 | $259.97 | $1.2M | Direct | May 10, 2019 (2d) |
| Feb 15, 2019 | ABMD | ↓ Sell | 20,000 | $360.16 | $7.2M | Direct | Feb 15, 2019 (0d) |
| Feb 6, 2019 | ABMD | ↓ Sell | 30,000 | $350.09 | $10.5M | Direct | Feb 6, 2019 (0d) |
| May 8, 2018 | ABMD | ↓ Sell | 21,890 | $343.50 | $7.5M | Direct | May 9, 2018 (1d) |
| May 29, 2015 | ABMD | ↑ Buy | 7,500 | $60.17 | $451K | Direct | Jun 2, 2015 (4d) |
| Aug 6, 2009 | LJPC | ↓ Sell | 2,240,433 | $0.19 | $416K | By Essex Woodlands Health Ventures Fund | Aug 7, 2009 (1d) |
| Jul 29, 2009 | LJPC | ↓ Sell | 112,880 | $0.18 | $21K | Direct | Aug 4, 2009 (6d) |
| Feb 27, 2009 | ABMD | ↑ Buy | 15,000 | $6.86 | $103K | Direct | Mar 2, 2009 (3d) |
| Feb 9, 2009 | ABMD | ↑ Buy | 10,000 | $9.08 | $91K | Direct | Feb 10, 2009 (1d) |
| Jan 23, 2009 | LJPC | ↑ Buy | 100,000 | $1.41 | $141K | Direct | Jan 23, 2009 (0d) |
| Nov 21, 2008 | ABMD | ↑ Buy | 15,000 | $10.96 | $164K | Direct | Nov 24, 2008 (3d) |
| Aug 18, 2008 | ABMD | ↑ Buy | 385,000 | $17.95 | $6.9M | Essex Woodlands Health Ventures Fund VII | Aug 20, 2008 (2d) |
| Aug 18, 2008 | ABMD | ↑ Buy | 165,000 | $17.95 | $3.0M | Essex Woodlands Health Ventures Fund VI, | Aug 20, 2008 (2d) |
| May 27, 2008 | ABMD | ↑ Buy | 10,000 | $13.88 | $139K | Direct | May 29, 2008 (2d) |
| May 12, 2008 | LJPC | ↑ Buy | 7,807,415 | $1.89 | $14.8M | By Essex Woodlands Health Ventures Fund | May 14, 2008 (2d) |
| May 12, 2008 | LJPC | ↑ Buy | 2,081,977 | $1.89 | $3.9M | By Essex Woodlands Health Ventures Fund | May 14, 2008 (2d) |
| Apr 4, 2007 | LJPC | ↑ Buy | 1,000,000 | $6.00 | $6.0M | By Essex Woodlands Health Ventures Fund | Apr 6, 2007 (2d) |
| Dec 14, 2005 | LJPC | ↑ Buy | 33,333,334 | $0.75 | $25.0M | By Essex Woodlands Health Ventures Fund | Dec 16, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Martin P Sutter's insider trades
Martin P Sutter is an insider at Abiomed (NASD). Since Dec 14, 2005, Martin has reported 12 open-market purchases worth $60.7M and 19 sales worth $50.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
8 sales (33% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (75 filings), option exercises (14 filings), other transactions (14 filings), shares returned to the company (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NASD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.